Background
People with HIV (PWH) on antiretroviral therapy (ART) often experience persistent immune activation despite viral suppression. IL-1β, a potent pro-inflammatory cytokine, has been implicated in vascular disease and atherogenesis. Here, we stratified ART-treated PWH by plasma IL-1β levels and investigated immune cell transcriptional profiles to uncover mechanisms that may link IL-1β to increased vascular risk.
Methods
We conducted single-cell RNA sequencing from PBMCs of 23 PWH on ART (11 high IL-1β [HILB], 12 low IL-1β [LILB]) selected from a retrospective case-cohort study of 1,002 PWH in the U.S. Military HIV Natural History Study. Participants were matched by age, gender, and incident vascular events (e.g., coronary artery disease, myocardial infarction, cerebrovascular accident, peripheral arterial disease). Plasma IL-1β was measured via MesoScale. scRNA-seq data were analyzed using Cell Ranger, Seurat, and Azimuth. Differential gene expression (DGE) and gene set enrichment analyses (GSEA) were conducted with MAST and MSigDB hallmark gene sets.
Results
Median log₁₀ IL-1β levels were 0.01 (HILB) vs. -1.2 (LILB). Groups were otherwise similar in age (mean 43.8 vs. 41.8 years), follow-up duration (9.3 vs. 7 years), gender (55% vs. 50% male), and co-morbidities and vascular risk factors (e.g., diabetes, hyperlipidemia, hypertension, smoking). DGE revealed that HILB participants had elevated IL1B and NFKB1 and reduced PECAM1 expression in non-classical CD16+ monocytes, suggesting increased inflammatory migration. Vascular-protective genes (LYZ, CFD) were downregulated in both CD14+ and CD16+ monocytes in HILB participants. Naïve CD4+ T cells from HILB participants showed increased PDCD4 (cell cycle regulation) and reduced BCL2 (anti-apoptotic) expression. GSEA showed upregulation of IL-6, TNF, and interferon signaling in most immune subsets in HILB, with downregulation of oxidative phosphorylation in CD16+ monocytes and NK cells.
Conclusions
This is the first study to assess IL-1β-related gene expression at the single-cell level in ART-treated PWH, controlling for age, gender, and vascular events. Elevated IL-1β may shift monocytes toward inflammatory, migratory states while suppressing vascular-protective genes, and impair naïve CD4+ T cell homeostasis, promoting immune exhaustion and apoptosis. Targeting the IL-1β/NF-κB axis or restoring vascular-protective monocyte programs could represent therapeutic strategies to reduce complications in treated HIV.
Table or Figure
